Fig. 2From: Mismatch repair-deficient hormone receptor-positive breast cancers: Biology and pathological characterizationNumber of clinical trials based on DNA repair alterations, including MMR deficiency. A total of 256 studies have been conducted on several different tumor types. Among these, only 11 studies involved patients with a diagnosis of breast cancer. None of them included HR+ breast cancers. HR+, hormone receptor-positiveBack to article page